PDL BioPharma Inc (NASDAQ:PDLI)

2.33
BATS BZX Real-Time Price
As of 10:13am ET
 -0.04 / -1.69%
Today’s Change
2.15
Today|||52-Week Range
3.55
-14.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line60.4M20.7M22.3M1.6M
 
 
 
 
 
Depreciation6.1M6.3M6.3M6.3M
 
 
 
 
 
Total Other Cash Flow-78.3M-34.0M-33.9M-8.3M
 
 
 
 
 
Funds From Operations2.2M-7.3M4.9M358.0K
 
 
 
 
 
Funds From/For Other Operating Expenses-13.6M-5.1M23.7M13.9M
 
 
 
 
 
Net Cash Flow - Operating Activities15.8M-2.1M-18.8M-13.5M
 
 
 
 
 
 
InvestingIncrease In Investments-3.9M-4.8M1.4M0.00
 
 
 
 
Decrease In Investments13.0M83.9M2.1M4.1M
 
 
 
 
 
Capital Expenditures-171.0K-455.0K-137.0K-1.4M
 
 
 
 
 
Net Assets From Acquisitions 0.00-2.2M0.000.00
 
 
Other Investing - Sources34.8M171.2M32.9M18.6M
 
 
 
 
 
Net Cash Flow Investing43.8M247.6M36.2M21.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings----0.000.00--
Long Term Debt Reduction-------126.4M
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-22.4M0.000.00-3.6M
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.00-201.0K0.00
 
 
Other Sources - Financing------0.00--
Other Uses - Financing2.2M84.8M0.000.00
 
 
 
Net Cash Flow - Financing-24.5M-84.8M-201.0K-130.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash35.1M160.7M17.2M-122.2M